Rainbow Foundat. (531694)
CyclicalScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹22.75 |
| Market Cap | ₹113.74 Cr |
| P/E Ratio | 30.93 |
| ROCE | 6.64% |
| ROE | 9.64% |
| Dividend Yield | 0% |
| Profit Growth | -27.27% |
| Debt/Equity | — |
| Sales Growth | 12.26% |
| 52-Week Range | ₹35.6 — ₹95.72 |
| Sector | Realty |
| Book Value | ₹15.17 |
Strengths
- Sales grew 12.26%, showing the business still generates demand.
- Book value of ₹15.17 provides some asset backing; stock trades at only 1.5 times book.
- Latest quarter remained profitable at ₹1 crore net profit, albeit thin.
- Price has fallen sharply from ₹127.90, so much pessimism may already be priced in.
Concerns
- Profit growth is deeply negative at -27.27%, while P/E is still 30.93.
- ROCE of 6.64% is below any reasonable cost of capital, indicating weak structural returns.
- Piotroski F-Score of 4/9 suggests poor financial health across fundamentals.
- Debt/Equity is undisclosed, and dividend yield is zero, offering no compensation for risk.
AI Analysis
Rainbow Foundation is exactly what Mr. Market offers when fear, not analysis, is doing the pricing. The stock has collapsed from ₹127.90 to ₹22.75, wiping out nearly 82% of its value. But a falling price is not automatically a bargain. At ₹114 crore market cap, the market is still paying 30.9 times trailing earnings. That is a rich multiple for a business whose profits fell 27.27% last year. The latest quarter earned just ₹1 crore on ₹38 crore of sales — a razor-thin 2.6% margin. This is not a franchise with pricing power; it is a marquee-less real estate player in a cyclical sector. Returns on capital are weak: ROE is 9.64% and ROCE is only 6.64%, which means management is earning less than the cost of capital. Book value of ₹15.17 and a P/B of 1.50 offer some cushion, but in property, book values can be illusionary if projects don't sell at the right price. Sales grew 12.26%, yet profits declined — growth without profit is value destruction. The Piotroski score of 4/9 confirms deteriorating financial health. There is no dividend to compensate while waiting. Debt/equity is undisclosed, and that opacity worries me more than a specific number would. In Graham's language, there is no margin of safety here. This is a speculative turnaround or cyclical recovery play, not a predictable compounder. I will wait for proof of stable margins, credible leverage disclosure, and returning capital before putting our money to work.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer